Ellen
1
SEK
-3.85 %
ELN
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
-3.85%
-7.41%
-4.76%
-11.5%
+1.01%
+1.01%
-76.46%
-90.42%
-98.95%
Ellen specializes in biotechnology. The company focuses on products for women's health. Ellen develops and sells sanitary protection for women based on probiotics (lactic acid bacteria). The products are sold under separate brands. The largest operations are held in the Nordic and European markets, where sales take place via licensed distributors. The company was established in 2000 and is headquartered in Stockholm.
Read moreMarket cap
11.08M SEK
Turnover
10.89K SEK
Revenue
25.59M
EBIT %
-11.68 %
P/E
-
Dividend yield-%
-
Financial calendar
28/2
2025
Annual report '24
22/5
2025
General meeting '24
ShowingAll content types
Marknadsuppdatering: Ellen AB förbättrar rörelseresultat för perioden januari till september 2024
Ellen AB offentliggör Halvårsrapport 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools